perioperative management · pdf fileperioperative management issues karen stierman, m.d. ......
TRANSCRIPT
Perioperative Management Issues Karen Stierman, M.D.
Faculty Advisor: Francis B. Quinn, M.D.
The University of Texas Medical Branch
Department of Otolaryngology
Grand Rounds Presentation
May 30, 2001
Perioperative Period
Defined as the time before,during and after the
operative procedure
Preoperative testing should include:
Pregnancy testing, childbearing age
Assessment of nutritional status
Hemoglobin(female)
Other tests as H&P indicates
Malnutrition
Mild to moderate
Weight loss 6-12% of normal, albumin 3.5g/dl, transferrin 200 mg/dl
Severe - weight loss >12%, low protein
NG versus TPN
Protein levels
Normal 0.8 g/kg/day
Ill 1.2 to 2.0 g/kg/day
TPN
Requires monitoring – avoid volume overload
Multiple times a day –VS, urine, glucose,acetone,
fluids
Daily – Weight, Lytes, I/O, protein, calories
Weekly – Liver function tests, serum
magnesium,protein, iron
TABLE 20-1. Blood components
Fraction Indication
Packed red blood cells Acute hemorrhage,symptomatic anemia
Fresh frozen plasma Coagulation abnormalities, hemoglobinopathy
Cryoprecipitate Low fibrinogen levels, coagulation
abnormalities,and hemoglobinopathy
Factor concentrates Specific factor deficits
Blood Transfusion
Monitor – hypersensitivity, volume overload, lytes,
acid/base, thrombocytopenia, hypothermia
Citrate toxicity – low ionized calcium
Autologous transfusion – can give 1 unit/72 hours
up to 72 hrs prior to surgery(HCT>33%)
Anemia
Hemoglobin <7g/dl in case with moderate
expected blood loss requires transfusion.
Chronic anemia or low blood loss patient may be
able to withstand
Anemia
Sickle cell
Trait;heterozygous, no tx
Disease;homozygous, transfuse to 50% HgS
Glucose-6-phosphate dehydrogenase
Men
Oxidant damage to Hg – lysis
Avoid certain meds
Thrombocytopenia
Platelet count<140,000/mL
DDX sepsis, drug induced, dilutional, DIC
Platelet count<50,000/mL – symptomatic
Each unit increases count by 5-10K
Half life 2- 3 days
Qualitative platelet disorders
Uremia, liver disease, previous bleeding d/o
NSAIDS, ASA
Correct underlying disorder
Desmopressin acetate
Coagulopathy
PT/PTT
Low risk – aortic valve, afib,previous DVT
D/C coumadin 1-2 days prior
High risk – mitral vave, cardiac emoboli,
D/C coumadin, begin heparin
Emergency
FFP- coumadin; Protamine sulfate – heparin
DVT
Risk factors
Obesity, cancer, immobilization, hypercoaguable states,
age greater than 40 years old
Diagnosis – Homan’s, fever, edema, pain, cord,
discoloration; Duplex US
Treatment – Heparin
P.E.
Sudden onset tachypnea, dyspnea, chest pain,
hemoptysis, hypoxia, arrhythmia
V/Q scan
Pulmonary angio
Heparin/oral anticoags
Diabetes
Fasting BG in all - incidence 1% and rises to 5%
for those over 40 yrs. old
In NPO patient, hold insulin or oral agent and
monitor glucose
Poor control – hold off on elective case
Goal 120-250 mg/dl
TABLE 20-3. Insulin coverage during surgery
For patients on oral hypoglycemic agents
Stop oral agents 24 h before surgery.
Insulin to control hyperglycemia (see below).
For insulin-dependent patient
Stop subcutaneous insulin pump.
On the morning of surgery, give one-third to one-
half of usual daily dose of intermediate-acting
insulin (NPH, Lente) subcutaneously. Supplement
with regular insulin during surgery dependent
on blood glucose.
Alternatively give regular insulin as a separate
constant infusion of 1–3 U/h, with rate
determined by the serum glucose measurements.
Ketoacidosis/Hyperosmolar coma
Ketoacidosis- IV bolus of 12-20 U reg. insulin and
constant infusion of 5-10u/hr
Hyperosmolar nonketotic hyperglycemia – lower
insulin doses
Fluids important
Potassium
Hypothyroid
Slow replacement better than rapid with
levothyroxine due to risk of adrenal insufficiency
and angina
Myxedema- Hydocortisone as well as synthroid
because stress response decreased.
Hyperthyroid
Reschedule if elective
Iodine – Inhibits thyroid hormone production, decreases vascularity
Steroid – stress response
Propanolol – B blocker
Antithyroid –
PTU blocks thyroid hormone production and inhibits conversion of T4-T3
Methamazole
TABLE 20-4. Medical control of thyrotoxic crisis
Propylthiouracil 300 mg p.o. every 6 h.
Iodine 5 drops saturated solution of potassium iodide
PO every 6–8 h or sodium iodide 500 mg i.v. Q12H.
Propranolol 1–2 mg i.v. as needed to keep pulse less
than 100.
Hydrocortisone 100 mg i.v. Q8H.
For congestive heart failure, digitalis and diuretics are
given and propranolol omitted.
Hypocalcemia
Thyroid/parathyroid surgery
Ca levels Q12 hrs(8mg/dL) until stable
Signs/Symptoms – Chvostek’s, Trousseau’s,
hyperreflexia, numbness/tingling in
extremities/circumoral.
Laryngeal stridor, overt tetany – emergencies
Calcium/ Vitamin D
Adrenal insufficiency
Suppressed hypothalmic/pituitary/adrenal axis
Stress during surgery – hypotension due to loss of
vascular tone
More than 5mg/day prednisone x 3 weeks in past
year
Currently on steroids, adrenal insuff., Cushings
TABLE 20-5. Replacement hydrocortisone sodium succinate
for adrenal-suppressed patients
Minor surgical procedures
usual daily cortisone dose
additional 100 mg i.m. before surgery
Major surgical procedures
100 mg i.v. or i.m. on call to operating room
100 mg i.v. on induction
100 mg i.v. q8h postoperatively
50 mg i.v. q8h on second postoperative day
Taper to maintenance over 3–5 days
Maintain 200–400 mg daily if ongoing stresses or
complications
i.v., intravenous, i.m., intramuscularly; q8h, every 8 hours.
DI/SIADH
DI – decreased ADH, decrease free water
reabsorption, dilute urine, hyperosmolar serum. Tx
with fluid intake, if severe-5% dextrose in water
with minimal sodium, DDAVP
SIADH – hyponatremia, concentrated urine, Tx
with fluid restriction, democlocyline(inhibits ADH
on kidney)
Cardiovascular
Routine ECG – men over 40 and women over 55.
Full eval if symptomatic
Med levels(digitalis) preop
Take hypertensive and cardiac meds preop.
No MAO or guanethidine 2 weeks prior to surgery
Hypertension
Anesthetic agents vasodilate
Hypervolemia, hypoventilation,pain, meds,
distended bladder/stomach, pre-existing
hypertension.
Correct underlying d/o
Nitroprusside
Hypotension
Hypovolemia, anesthesia, meds, cardiac
dysfunction,pulmonary d/o
Fluid challenge
Wedge pressure
Sepsis
Vasopressors
Arrythmias
Cardiac dz,hypoxia, hypotension,
acid/base/electrolyte
Supraventricular tachy – adenosine, verapamil,
propanolol, diltiazem
Afib/flutter – Digoxin
Ventricular tach- lidocaine
Cardiology consult
Pulmonary considerations
Mechanical vent – alveolar hypovent with V/Q
abnormalities
History/Physical – smoker, dyspnea
ACS – CXR greater than 40 yrs old, high risk for
pulmonary disease
Avoid fluid overload
IS/Deep breath
Pulmonary considerations
Reactive airway – nebs
Brochoscopy – mucous plug
Wedge
PAWP > 25 mm HG- cardiogenic – fluid
restrict/diuretics
ARDS – normal PAWP, pulmonary edema, target
cause, supportive measures
GI
Ulcers
H2 blocker
Massive GI bleed, NGT, GI consult
Intestinal motility – ileus, check for BS prior to feeding, Xray – distended loops of bowel and diffuse gas, Tx with NGT
Diarrhea – Clostridium, clinda/amp most common but others can cause, Tx with fluids and Vanc.
Renal
Dialysis
Platelet dysfunction, anemia, hypertension, lytes
ATN – ischemia or nephrotoxicity, urine casts, low
urine/plasma creatinine, nephro consult
Neuropsychiatric
Seizures
Heart, metabolic, drug/etoh, CNS
Determine cause, airway/vent, Tx with benzo’s phenytoin,barbituates
Myasthenia gravis – continue anticholinesterase meds. Avoid quinidine, curare,lithium,B-blockers,phenytoin, aminoglycosides
Delerium versus dementia
TABLE 20-8. Pharmacologic management of status epilepticus
Agent Dosage
Diazepam
Adults i.v. bolus of 5–10 mg at 1–2 mg/min to maximum of 20–
30 mg or continuous infusion 4–8 mg/h to total daily dose of 1–4
mg/kg
Children 1 mg/yr of age to total dose of 5–10 mg
Lorazepam 2–4 mg i.v. slowly q5–10 min to total dose of 8 mg
Phenytoin
Adults Loading dose of 15–20 mg/kg at 30–50 mg/min
Children Loading dose of 10–20 mg/kg at 0.5–1.5 mg/kg/min
Phenobarbital Loading dose of 10–20 mg/kg i.v. (initial bolus 200–300
mg), repeated in 20 min
Supportive
Glucose
Adult: 50 mL of a 50% solution
Children: 1–2 mL/kg of a 25% solution
Thiamine 100 mg i.v.
Calcium gluconate 1–2 amps for recent thyroid or
parathyroid surgery
TABLE 20-9. Pharmacologic management of delirium
Hepatic encephalopathy
Short-acting benzodiazepines (e.g., oxazepam,
15–30 mg q6h)
Alcohol withdrawal (i.v., Q1–2h)
Chlordiazepoxide, 25–50 mg
Diazepam, 5–10 mg
Lorazepam, 2 mg
Other forms of delirium
Haloperidol
Mild agitation 2–15 mg p.o. twice daily (elderly 0.5–3.0 mg daily)
More severe agitation 2–10 mg i.m. hourly until sedation
obtained (10–60 mg/day usually sufficient)
Urgent 1–5 mg i.v. with increases of 5–10 mg/h
Chlorpromazine
All cases 25–50 mg i.m. h if blood pressure adequate
i.v., intravenous, i.m., intramuscularly
TABLE 20-10. Postoperative causes of fever
Noninfectious causes
Hematoma and tissue trauma
Atelectasis
Nonseptic phlebitis and deep venous thrombosis
Drug of anesthetic allergies
Transfusion reactions
Presence of drains or catheters
Less common noninfectious causes
Activation of inflammatory disease (lupus,
rheumatoid arthritis)
Endocrine excess (thyroid storm)
Hypothalamic abnormalities
Infectious sites
Wound
Urinary tract
Respiratory
Intravenous line site
Infected prosthesis or foreign body
Meningitis (especially in skull-base surgery)
TABLE 20-11. Treatment of malignant hyperthermia
Signs
Sharp increase in core body temperature
Cardiac arrhythmias
Excessive bleeding
Rise in end-tidal carbon dioxide concentration
Management
Stop succinylcholine and inhalation agent
immediately
100% oxygen
Dantrolene sodium, 2.5 mg/kg i.v. q5–10 min as
necessary to maximum dose of 10 mg/kg
Sodium bicarbonate, 1–2 mEq/kg i.v. (monitor blood
gases)
Support therapy
Remove drapes
Lower core temperature with iced saline (i.v.,
rectally or intragastrically)
Application of ice to exposed body parts
Watch for hyperkalemia, acidosis, myoglobinuria,
arrhythmias, and posttreatment hypothermia
TABLE 20-12. Pharmacologic management of postoperative pain
Drugs Dose
Opioids Initial dose
Morphine 10 mg i.m. or 5–10 mg i.v. then 3
mg/h continuous i.v. infusion
PCA: Demand 0.5–3.0 mg, lock
out 5–12 min
Children: 0.07–0.1 mg/kg/i.v. q2h
Meperidine 75–100 mg i.m. or 25–50 mg i.v.,
then 25 mg/hr infusion
PCA: Demand 5–30 mg, lock out
5–12 min
Buprenorphine 0.3 mg i.m. or i.v., q6–8h
Nonsteroidal antiinflammatory drugs
Indomethacin 50–100 mg q6–8h
Ibuprofen 200–400 mg q4–6h
Ketorolac 30 mg i.v. or i.m., q6h (maximum
5 days)
i.m., intramuscularly; i.v., intravenously; q2h, every 2 hours; q6-8h,
every 6 to 8 hours; PCA, patient controlled analgesia.